Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
PellePharm to Participate in the Cantor Fitzgerald Dermatology and Aesthetics Summit
-
Majesco Entertainment (COOL) PT Lowered to $65 at Cantor Fitzgerald
-
Three Years in a Row: Makor Wins EXEL Title for Best Special Situations Sales
-
Pre-Open Movers 06/12: (GLMD) (RH) (PLAY) Higher; (IDRA) (JCAP) (IMMU) Lower (more...)
-
Evolus (EOLS) PT Raised to $35 at Cantor Fitzgerald
-
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
-
After-Hours Stock Movers 06/11: (RH) (PLAY) (PFNX) Higher; (JCAP) (IMMU) (HOME) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts AcelRx Pharmaceuticals (ACRX) at Overweight
-
UPDATE: Cantor Starts Collegium Pharmaceutical (COLL) at Outperform
-
Cantor Fitzgerald Starts Biohaven Pharmaceutical Holding (BHVN) at Overweight
-
Cantor Fitzgerald Starts ANI Pharmaceuticals (ANIP) at Overweight
-
Cantor Fitzgerald Starts Momenta Pharmaceuticals (MNTA) at Neutral
-
Cantor Fitzgerald Starts Eagle Pharmaceuticals (EGRX) at Overweight
-
Cantor Fitzgerald Starts Emergent BioSolutions (EBS) at Overweight
-
Cantor Fitzgerald Starts OPNET Technologies (OPNT) at Overweight
-
Freddie Mac Prices $814 Million Multifamily K-Deal, K-1505
-
U.S. stocks rise ahead of North Korea summit, despite Trump's G7 fireworks
-
Cantor Fitzgerald Reiterates Overweight on Allscripts (MDRX)
-
Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
-
Cantor Fitzgerald Starts Pfizer (PFE) at Overweight
-
Jack Henry (JKHY) PT Raised to $141 at Cantor Fitzgerald
-
Athenahealth CEO steps down; company considers sale
-
U.S. judge throws out Nomura bond trader's conviction
-
Mike Won Joins White Oak Healthcare Finance to Bolster Origination Efforts
-
PolarityTE (COOL) Prices $55M Follow-on Offering of Common Stock
-
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
-
PolarityTE Announces Pricing of Public Follow-on Offering of Common Stock
-
Coupa Software (COUP) PT Raised to $67 at Cantor Fitzgerald
-
HealthEquity, Inc (HQY) PT Raised to $68 at Cantor Fitzgerald
-
PolarityTE (COOL) Announces Proposed Common Offering
-
PolarityTE Announces Public Offering of Common Stock
-
PolarityTE Announces Public Offering of Common Stock
-
Teladoc (TDOC) PT Raised to $50 at Cantor Fitzgerald Following Acquisition of Advanced Medical
-
Square (SQ) PT Raised to Street High $69 at Cantor Following Weebly Acquisition
-
UPDATE: Cantor Fitzgerald Starts Ventas (VTR) at Neutral
-
UPDATE: Cantor Fitzgerald Starts NuVasive (NUVA) to Neutral
-
Cantor Fitzgerald Starts Orthofix International (OFIX) at Overweight
-
Cantor Fitzgerald Starts Mazor Robotics (MZOR) at Neutral
-
Cantor Fitzgerald Starts K2M Group Holdings (KTWO) at Overweight
-
Cantor Fitzgerald Starts Globus Medical (GMED) at Overweight
-
Cantor Fitzgerald Starts SeaSpine Holdings (SPNE) at Overweight
-
Realm Therapeutics to Present at June Investor Conferences
-
Cantor Fitzgerald Upgrades Quality Systems (QSII) to Overweight
-
Cantor Fitzgerald Downgrades HealthEquity, Inc (HQY) to Neutral
-
Buy Amarin Corp. (AMRN) Ahead Of REDUCE-IT Data - Cantor Fitzgerald
-
Melinta Therapeutics Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Melinta Therapeutics Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
ProPhotonix Delivers 3m COBRA RGB Line Light to Leading Inkjet Printer Manufacturer
-
Form SC 13D/A BGC Partners, Inc. Filed by: CANTOR FITZGERALD, L. P.
-
Teva Settlement Favorable for Amarin (AMRN) - Cantor Fitzgerald

